Analysis of prognostic factors in ovarian clear cell carcinoma: a retrospective cohort study

Read full text Summarise with VIRAT
Authors: Xingyun Xie, Yuting Wei, Chenying Liu, Siyi Li, Wenjuan Chen
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Ovarian clear cell carcinoma (OCCC) is a rare histological subtype of ovarian cancer, often associated with endometrial lesions, and characterized by poor prognosis and a high propensity for recurrence and metastasis. This study aimed to investigate the clinical characteristics of patients with OCCC and identify prognostic factors. Methods: A retrospective analysis was conducted on patients diagnosed with OCCC at Fujian Cancer Hospital from January 2007 to December 2018. Inclusion criteria were as follows: (I) histologically confirmed pure OCCC; (II) surgical intervention; (III) standardized and completed postoperative follow-up. Exclusion criteria were as follows: (I) patients with recurrence or metastasis; (II) patients who did not receive treatment. Kaplan-Meier survival curves were used to estimate progression-free survival (PFS) and overall survival (OS). Clinical outcomes were further analyzed using Cox proportional hazards regression. Results: The median follow-up duration for 102 patients was 89.62 months. At the time of the final follow-up, 44 patients had died, and 43 had experienced recurrence or metastasis. The 5-year OS and PFS rates were 59.2% and 50.0%, respectively. Univariate Cox regression analysis indicated that stage, concurrent endometriosis, chemotherapy, carbohydrate antigen 125 (CA-125) normalization, and CA-125 ≤20 U/mL were associated with both OS and PFS (P

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Endometrial and Cervical Cancer Treatments Ovarian function and disorders

Publication details

Journal / source
Translational Cancer Research
Volume
15
Issue
3
Pages
156–156
Publication date
1 March 2026
Language
EN